logo
Twitter
Discord
Email
logo
Balchem Corporation

Balchem Corporation

NASDAQ•BCPC
CEO: Mr. Theodore L. Harris
Sector: Basic Materials
Industry: Chemicals - Specialty
Listing Date: 1986-06-03
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Contact Information
5 Paragon Drive, Montvale, NJ, 07645, United States
845-326-5600
www.balchem.com
Market Cap
$4.99B
P/E (TTM)
33.7
vs Industry 31.1
Dividend Yield (TTM)
0.6%
52W High
$185.96
52W Low
$139.17
52W Range
32%
6.2
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Strong • 6.2 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2015-2024

Financial Dashboard

Q3 2025 Data

Revenue

$267.56M+11.51%
4-Quarter Trend

EPS

$1.25+20.19%
4-Quarter Trend

FCF

$50.67M+20.20%
4-Quarter Trend

Earnings Highlights

Key Highlights

No Data Available

Risk Factors

No Data Available

Outlook

No Data Available

Peer Comparison

Revenue (TTM)

Sasol LimitedSSL
$29.13B
+0.5%
Celanese CorporationCE
$9.94B
-5.8%
Axalta Coating Systems Ltd.AXTA
$5.17B
-1.0%

Gross Margin (Latest Quarter)

Perimeter Solutions, Inc.PRM
63.1%
+0.3 pp
SSR Mining Inc.SSRM
53.3%
+41.9 pp
Element Solutions IncESI
42.2%
+0.7 pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
ESI$6.28B26.29.4%32.2%
AXTA$6.21B13.521.3%0.3%
BCPC$4.99B33.712.1%11.4%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4-Quarter Revenue CAGR
+3.7%
Moderate Growth
4-Quarter Net Income CAGR
+6.3%
Gradual Improvement in Profitability
Cash Flow Stability
100%
Strong Cash Flow Performance

Research & Insights

Reports
All Years
  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Jul 31, 2025|
    Revenue: $255.47M+9.1%
    |
    EPS: $1.18+19.2%
    Beat
  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: Apr 24, 2025|
    Revenue: $250.52M+4.5%
    |
    EPS: $1.14+26.7%
    Beat
  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Feb 21, 2025|
    Revenue: $953.68M+3.4%
    |
    EPS: $3.97+17.5%
    Meet
  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Oct 25, 2024|
    Revenue: $239.94M+4.3%
    |
    EPS: $1.04+14.3%
    Miss
  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Jul 26, 2024|
    Revenue: $234.08M+1.2%
    |
    EPS: $0.99+5.3%
    Miss
  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: May 3, 2024|
    Revenue: $239.66M+3.1%
    |
    EPS: $0.90+26.8%
    Miss
  • Form 10-K - FY 2023

    Period End: Dec 31, 2023|Filed: Feb 16, 2024|
    Revenue: $922.44M-2.1%
    |
    EPS: $3.38+2.7%
    Miss
  • Form 10-Q - Q3 2023

    Period End: Sep 30, 2023|Filed: Oct 27, 2023|
    Revenue: $229.95M-5.9%
    |
    EPS: $0.91+15.2%
    Miss